Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyunsuk Shim

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Biochemical and Biophysical Research Communications|June 8, 2006
Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alphaHyunsuk Shim, Stephen K Lau, Sarojini Devi, et al.
Bioorganic & Medicinal Chemistry|September 1, 2016
Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitorsTheresa Gaines, Davita Camp, Renren Bai, et al.
European Journal of Medicinal Chemistry|November 8, 2019
Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axisRui Wu, Wenyan Yu, Chuansheng Yao, et al.
Gastroenterology|December 8, 2010
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cellsSei-Jung Lee, Stefanie L Ritter, Huanchun Zhang, et al.
Journal of Medicinal Chemistry|October 26, 2007
Discovery of small molecule CXCR4 antagonistsWeiqiang Zhan, Zhongxing Liang, Aizhi Zhu, et al.
American Journal of Physiology. Cell Physiology|February 25, 2005
LPA2 receptor mediates mitogenic signals in human colon cancer cellsC Chris Yun, Hong Sun, Dongsheng Wang, et al.
Bioorganic & Medicinal Chemistry|December 18, 2019
A benzenesulfonamide derivative as a novel PET radioligand for CXCR4Yoon Hyeun Oum, Dinesh Shetty, Younghyoun Yoon, et al.
AJR. American Journal of Roentgenology|July 24, 2014
Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitorHyunsuk Shim, Li Wei, Chad A Holder, et al.
Chemmedchem|March 8, 2013
Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitorsSuazette Reid Mooring, Jin Liu, Zhongxing Liang, et al.
European Journal of Medicinal Chemistry|August 5, 2019
Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitorsTheresa Gaines, Francisco Garcia, Saniya Virani, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|June 8, 2006
Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alphaHyunsuk Shim, Stephen K Lau, Sarojini Devi, et al.
Bioorganic & Medicinal Chemistry|September 1, 2016
Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitorsTheresa Gaines, Davita Camp, Renren Bai, et al.
European Journal of Medicinal Chemistry|November 8, 2019
Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axisRui Wu, Wenyan Yu, Chuansheng Yao, et al.
Gastroenterology|December 8, 2010
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cellsSei-Jung Lee, Stefanie L Ritter, Huanchun Zhang, et al.
Journal of Medicinal Chemistry|October 26, 2007
Discovery of small molecule CXCR4 antagonistsWeiqiang Zhan, Zhongxing Liang, Aizhi Zhu, et al.
American Journal of Physiology. Cell Physiology|February 25, 2005
LPA2 receptor mediates mitogenic signals in human colon cancer cellsC Chris Yun, Hong Sun, Dongsheng Wang, et al.
Bioorganic & Medicinal Chemistry|December 18, 2019
A benzenesulfonamide derivative as a novel PET radioligand for CXCR4Yoon Hyeun Oum, Dinesh Shetty, Younghyoun Yoon, et al.
AJR. American Journal of Roentgenology|July 24, 2014
Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitorHyunsuk Shim, Li Wei, Chad A Holder, et al.
Chemmedchem|March 8, 2013
Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitorsSuazette Reid Mooring, Jin Liu, Zhongxing Liang, et al.
European Journal of Medicinal Chemistry|August 5, 2019
Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitorsTheresa Gaines, Francisco Garcia, Saniya Virani, et al.
Pageof 10